CME STP Impacts for CME FX Link and FX Spot Plus
This topic provides CME STP Impacts for CME FX Link trades with the introduction of FX Spot+.
Effective Sunday, April 13 (trade date April 14), CME Group will launch CME FX Spot+, a new tradable FX spot instrument, leveraging CME FX Link liquidity to bring together OTC spot FX and FX futures. As STP API updates continue, FX Link Spot leg trades will be updated to align with spot products.
CME FX Link - The CME Globex spot-futures basis spread is a CME Globex spread between OTC spot FX and a related CME FX futures contract of the same currency pair. The futures leg of this spread will clear via CME Clearing exactly the same as all other futures contracts traded in CME Group markets, while the spot position resulting from transactions in the spread (that is tradable via the spread) will be intermediated by a spot central credit counterparty that will face applicable FX Prime Broker (FXPB) of the trade counterparties.
CME FX Spot+ (New) - All-to-all spot FX marketplace seamlessly connected to CME FX futures liquidity. CME FX Spot+ will enable spot FX market participants to tap into CME FX futures liquidity through an open, transparent central limit order book while giving FX futures users broader access to OTC liquidity. This unique liquidity connection will be made possible by implied matching through CME FX Link, a liquid, tradable spread between OTC spot FX and FX futures.
Topic | Details |
---|---|
This topic details CME STP Impacts for clients who trade and receive Trade capture reports of FX Link spread. | |
This topic details CME STP impacts that are applicable to EBS clients who participate in CME FX Spot+ market. |
Contact Information
For technical development support, contact Certification Support for Electronic Trading (CSET).
For production requests, please contact the Global Command Center (GCC).
For all other inquiries, please contact Global Account Management (GAM).
Related content
How was your Client Systems Wiki Experience? Submit Feedback
Copyright © 2024 CME Group Inc. All rights reserved.